BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26261674)

  • 1. Concurrent Epstein-Barr virus associated NK/T cell lymphoma after immunosuppressive therapy for aplastic anemia: report of a case and review of literature.
    Yin G; Ni Y; Xiao Z; He G; Miao K
    Int J Clin Exp Pathol; 2015; 8(6):7588-93. PubMed ID: 26261674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
    Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
    Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
    Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma.
    Toksoy A; Strifler S; Benoit S; Grigoleit GU; Knop S; Mielke S; Buder-Bakhaya K; Roth S; Goebeler M; Rosenwald A; Geissinger E; Wobser M
    Acta Derm Venereol; 2017 Mar; 97(3):379-380. PubMed ID: 27826612
    [No Abstract]   [Full Text] [Related]  

  • 9. Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.
    Tomoka T; Powers E; van der Gronde T; Amuquandoh A; Dhungel BM; Kampani C; Kamiza S; Montgomery ND; Fedoriw Y; Gopal S
    BMC Cancer; 2017 Sep; 17(1):633. PubMed ID: 28877678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Intravascular NK/T-cell lymphoma mimic panniculitis clinically, case report and literature brief review.
    Alhumidi A
    Diagn Pathol; 2015 Jul; 10():107. PubMed ID: 26178620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
    Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
    BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.
    Fox CP; Haigh TA; Taylor GS; Long HM; Lee SP; Shannon-Lowe C; O'Connor S; Bollard CM; Iqbal J; Chan WC; Rickinson AB; Bell AI; Rowe M
    Blood; 2010 Nov; 116(19):3695-704. PubMed ID: 20671118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease.
    Moran NR; Webster B; Lee KM; Trotman J; Kwan YL; Napoli J; Leong RW
    World J Gastroenterol; 2015 May; 21(19):6072-6. PubMed ID: 26019475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
    Ito Y; Kimura H; Maeda Y; Hashimoto C; Ishida F; Izutsu K; Fukushima N; Isobe Y; Takizawa J; Hasegawa Y; Kobayashi H; Okamura S; Kobayashi H; Yamaguchi M; Suzumiya J; Hyo R; Nakamura S; Kawa K; Oshimi K; Suzuki R
    Clin Cancer Res; 2012 Aug; 18(15):4183-90. PubMed ID: 22675173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
    Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
    Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of early diagnosis on the prognosis of extranodal NK/T-cell lymphoma with massive lung involvement: a case report.
    Yabushita T; Yoshioka S; Furumiya T; Nakamura M; Yamashita D; Imai Y; Ishikawa T
    BMC Pulm Med; 2019 Feb; 19(1):48. PubMed ID: 30791900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
    Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
    Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK/T cell lymphoma involving mediastinum: report of a case and review of literature.
    Li X; Liao WH; Zhou JH; Liu BA; Wen JF; Hu ZL
    Int J Clin Exp Pathol; 2014; 7(9):6399-402. PubMed ID: 25337299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.